{"name":"Archimedes Pharma","permalink":"archimedes-pharma","crunchbase_url":"http://www.crunchbase.com/company/archimedes-pharma","homepage_url":"http://www.archimedespharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2004,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"timwatts@archimedespharma.com","phone_number":"+44 (0)118 931 5050","description":"","created_at":"Wed Mar 03 04:44:54 UTC 2010","updated_at":"Wed Jun 20 20:17:57 UTC 2012","overview":"<p>Archimedes Pharma Limited operates as a specialty pharmaceutical company. Its products include Gliadel, for high grade glioma; Zomorph, an oral sustained release morphine product for cancer pain; Nozinan that treats nausea and vomiting in cancer patients; Pabrinex, a formulation of vitamins B and C for alcoholics experiencing acute withdrawal; and Nasalfent, an intranasal fentanyl for relief of cancer pain. The company was founded in 2004 and is headquartered in Reading, the United Kingdom. It has operations in the United Kingdom, France, and Germany.</p>","image":{"available_sizes":[[[150,51],"assets/images/resized/0007/8870/78870v1-max-150x150.jpg"],[[220,75],"assets/images/resized/0007/8870/78870v1-max-250x250.jpg"],[[220,75],"assets/images/resized/0007/8870/78870v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Jeffrey","last_name":"Buchalter","permalink":"jeffrey-buchalter","image":null}},{"is_past":false,"title":"Interim COO & CFO","person":{"first_name":"Tim","last_name":"Watts","permalink":"tim-watts","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$99M","funding_rounds":[{"round_code":"c","source_url":"http://onbiovc.com/archimedes-pharma-ltd-series-c-99m/","source_description":"Archimedes Pharma, Ltd.: Series C $99M ","raised_amount":99000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":5,"investments":[{"company":null,"financial_org":{"name":"Warburg Pincus","permalink":"warburg-pincus","image":{"available_sizes":[[[150,50],"assets/images/resized/0001/9008/19008v1-max-150x150.png"],[[250,83],"assets/images/resized/0001/9008/19008v1-max-250x250.png"],[[413,138],"assets/images/resized/0001/9008/19008v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Novo A/S","permalink":"novo-a-s","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"250 South Oak Way","address2":"Green Park","zip_code":"RG2 6UG","city":"Reading","state_code":null,"country_code":"FRA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,102],"assets/images/resized/0007/8869/78869v1-max-150x150.jpg"],[[250,170],"assets/images/resized/0007/8869/78869v1-max-250x250.jpg"],[[450,306],"assets/images/resized/0007/8869/78869v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}